FDA Urges 2,200 Sponsors to Publicly Disclose Trial Results
The FDA reminded more than 2,200 sponsors and researchers to submit mandatory clinical trial results to ClinicalTrials.gov, flagging risks from publication bias and incomplete public records. An internal review found about 29.6% of studies likely required to report have no results, and the agency issued voluntary compliance messages on March 30, 2026, with potential for noncompliance notices to ensure results are released for patient safety and informed clinical decisions.